# Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study

> **NCT03951142** · PHASE2 · UNKNOWN · sponsor: **Kyrre Eeg Emblem** · enrollment: 165 (estimated)

## Conditions studied

- Glioblastoma
- Brain Metastases

## Interventions

- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT03951142
- **Lead sponsor:** Kyrre Eeg Emblem
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03951142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03951142, "Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT03951142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*